• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION VISIONIST X4 CRT-P; PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION VISIONIST X4 CRT-P; PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P) Back to Search Results
Model Number U228
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Fall (1848); Intracranial Hemorrhage (1891); Syncope/Fainting (4411); Asystole (4442); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/24/2022
Event Type  Death  
Event Description
It was reported that the pacemaker entered safety mode and was subsequently replaced.The device is expected to be returned to boston scientific for analysis.No additional adverse patient effects were reported.
 
Event Description
It was reported that the pacemaker entered safety mode and was subsequently replaced.The device is expected to be returned to boston scientific for analysis.No additional adverse patient effects were reported.It was additionally reported that the day prior to discovering the device was in safety mode the patient experienced three or four episodes of syncope (asystole of approximately seven seconds) and as a result, had a fall.The fall caused a subarachnoid hemorrhage.It was stated that the patient was doing ok following the device replacement, though the treatment required for the hemorrhage was not reported.
 
Event Description
It was reported that the pacemaker entered safety mode and was subsequently replaced.The device is expected to be returned to boston scientific for analysis.No additional adverse patient effects were reported.It was additionally reported that the day prior to discovering the device was in safety mode the patient experienced three or four episodes of syncope (asystole of approximately seven seconds) and as a result, had a fall.The fall caused a subarachnoid hemorrhage.It was stated that the patient was doing ok following the device replacement, though the treatment required for the hemorrhage was not reported.The device has been received and analysis is in-progress.Additional information was received indicating the patient expired due to complications related to the previously reported fall.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, this device was thoroughly inspected and analyzed.Interrogation of the device confirmed it was operating in safety mode and that bradycardia therapy remained available.Engineers determined that this device was demonstrating behavior consistent with a high internal cell impedance within the battery.The high internal impedance put this device at risk of experiencing transient voltage decreases (and associated resets) during periods of high-power consumption.When battery voltage drops below a minimum threshold a system reset is performed.If three system resets occur within a 48-hour period, the device is designed to immediately enter safety mode operation to maintain back-up pacing with pre-defined, non-programmable settings.
 
Event Description
It was reported that the pacemaker entered safety mode and was subsequently replaced.The device is expected to be returned to boston scientific for analysis.No additional adverse patient effects were reported.It was additionally reported that the day prior to discovering the device was in safety mode the patient experienced three or four episodes of syncope (asystole of approximately seven seconds) and as a result, had a fall.The fall caused a subarachnoid hemorrhage.It was stated that the patient was doing ok following the device replacement, though the treatment required for the hemorrhage was not reported.The device has been received and analysis is in-progress.Additional information was received indicating the patient expired due to complications related to the previously reported fall.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VISIONIST X4 CRT-P
Type of Device
PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key14733152
MDR Text Key294265203
Report Number2124215-2022-21877
Device Sequence Number1
Product Code NKE
UDI-Device Identifier00802526559471
UDI-Public00802526559471
Combination Product (y/n)N
Reporter Country CodeFI
PMA/PMN Number
P030005/S138
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 02/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/20/2018
Device Model NumberU228
Device Catalogue NumberU228
Device Lot Number706812
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/14/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/25/2022
Initial Date FDA Received06/17/2022
Supplement Dates Manufacturer Received05/30/2022
08/26/2022
02/02/2023
Supplement Dates FDA Received06/22/2022
09/20/2022
02/27/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/02/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Death; Hospitalization; Life Threatening;
-
-